WSR 18-03-139
[Filed January 22, 2018, 11:36 a.m.]
Original Notice.
Preproposal statement of inquiry was filed as WSR 17-05-075.
Title of Rule and Other Identifying Information: WAC 260-70-640 Permitted medications.
Hearing Location(s): On March 9, 2018, at 9:30 a.m., at the Auburn City Council Chambers, 25 West Main, Auburn, WA 98002.
Date of Intended Adoption: March 9, 2018.
Submit Written Comments to: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516, email, fax 360-549-6461 [360-459-6461], by March 2, 2018.
Assistance for Persons with Disabilities: Contact Patty Brown, phone 360-459-6462, fax 360-459-6461, email, by March 6, 2018.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: To update current industry standards in threshold levels for permitted medication.
Reasons Supporting Proposal: To adopt recommended ARCI and RMTC thresholds for permitted medications that would move Washington into uniformity with the majority of other racing jurisdictions. The threshold levels have been established to ensure the equine athlete is protected and safe.
Statutory Authority for Adoption: RCW 67.16.020.
Rule is not necessitated by federal law, federal or state court decision.
Name of Agency Personnel Responsible for Drafting, Implementation, and Enforcement: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516, 360-459-6462.
A school district fiscal impact statement is not required under RCW 28A.305.135.
A cost-benefit analysis is not required under RCW 34.05.328.
The proposed rule does not impose more-than-minor costs on businesses. Following is a summary of the agency's analysis showing how costs were calculated. Not business related.
January 22, 2018
Douglas L. Moore
Executive Secretary
AMENDATORY SECTION (Amending WSR 16-09-015, filed 4/11/16, effective 5/12/16)
WAC 260-70-640 Permitted medication.
Trainers using permitted medication in the care of their horses are subject to all rules governing such medications. Failure to administer permitted medication to a horse on a program of permitted medication is a violation of these rules.
(1) The use of one of three approved nonsteroidal anti-inflammatory drugs (NSAIDs) is permitted under the following conditions:
(a) The drug may not exceed the following permitted serum or plasma threshold concentrations, which are consistent with administration by a single intravenous injection at least twenty-four hours before the post time for the race in which the horse is entered:
(i) Phenylbutazone - ((5)) 2.0 micrograms per milliliter ((in overnight and nongraded stakes races, and 2 micrograms per milliliter in graded stakes races));
(ii) Flunixin - ((50)) 20 nanograms per milliliter;
(iii) Ketoprofen - ((10)) 2 nanograms per milliliter.
(b) No NSAID, including the approved NSAIDs listed in this rule, may be administered within the twenty-four hours before post time for the race in which the horse is entered.
(c) The presence of a second approved NSAID will ((not)) be considered a violation if the second of the approved NSAIDs is ((not)) over the secondary threshold as follows:
(i) Phenylbutazone - ((1)) 0.3 mcg per milliliter;
(ii) Flunixin - 3 ng per milliliter;
(iii) Ketoprofen - 1 ng per milliliter.
(d) Any unapproved NSAID in the post-race serum or plasma sample is not permitted. The use of all but one of the approved NSAIDs must be discontinued at least forty-eight hours before the post time for the race in which the horse is entered.
(2) Any horse to which a NSAID has been administered is subject to having a blood and/or urine sample(s) taken at the direction of an official veterinarian to determine the quantitative NSAID level(s) and/or the presence of other drugs which may be present in the blood or urine sample(s).